Controlling silk fibroin particle features for drug delivery.

Silk proteins are a promising material for drug delivery due to their aqueous processability, biocompatibility, and biodegradability. A simple aqueous preparation method for silk fibroin particles with controllable size, secondary structure and zeta potential is reported. The particles were produced by salting out a silk fibroin solution with potassium phosphate. The effect of ionic strength and pH of potassium phosphate solution on the yield and morphology of the particles was determined. Secondary structure and zeta potential of the silk particles could be controlled by pH. Particles produced by salting out with 1.25 m potassium phosphate pH 6 showed a dominating silk II (crystalline) structure whereas particles produced at pH 9 were mainly composed of silk I (less crystalline). The results show that silk I-rich particles possess chemical and physical stability and secondary structure which remained unchanged during post treatments even upon exposure to 100% ethanol or methanol. A model is presented to explain the process of particle formation based on intra- and intermolecular interactions of the silk domains, influenced by pH and kosmotropic salts. The reported silk fibroin particles can be loaded with small molecule model drugs, such as alcian blue, rhodamine B, and crystal violet, by simple absorption based on electrostatic interactions. In vitro release of these compounds from the silk particles depends on charge-charge interactions between the compounds and the silk. With crystal violet we demonstrated that the release kinetics are dependent on the secondary structure of the particles.

[1]  Thomas Scheibel,et al.  Polymeric materials based on silk proteins , 2008 .

[2]  J. Swarbrick,et al.  Albumin Microspheres as a Drug Delivery System: Relation Among Turbidity Ratio, Degree of Cross-linking, and Drug Release , 1993, Pharmaceutical Research.

[3]  D. Kaplan,et al.  In vivo degradation of three-dimensional silk fibroin scaffolds. , 2008, Biomaterials.

[4]  D. Kaplan,et al.  Silk microspheres for encapsulation and controlled release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Lorenz Meinel,et al.  Silk fibroin spheres as a platform for controlled drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Thomas Scheibel,et al.  Hierarchical structures made of proteins. The complex architecture of spider webs and their constituent silk proteins. , 2010, Chemical Society reviews.

[7]  R. Arshady,et al.  Review : Biodegradable Microcapsular Drug Delivery Systems: Manufacturing Methodology, Release Control and Targeting Prospects , 1990 .

[8]  S. Gorb,et al.  An engineered spider silk protein forms microspheres. , 2008, Angewandte Chemie.

[9]  Thomas Scheibel,et al.  Spider silk: from soluble protein to extraordinary fiber. , 2009, Angewandte Chemie.

[10]  T. Scheibel,et al.  Hierarchical Structures Made of Proteins. The Complex Architecture of Spider Webs and Their Constituent Silk Proteins , 2010 .

[11]  Robert Langer,et al.  Advances in Biomaterials, Drug Delivery, and Bionanotechnology , 2003 .

[12]  David L. Kaplan,et al.  Determining Beta-Sheet Crystallinity in Fibrous Proteins by Thermal Analysis and Infrared Spectroscopy , 2006 .

[13]  A. Albertsson Degradable aliphatic polyesters , 2002 .

[14]  M. Ercan,et al.  Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Hua-Jie Wang,et al.  Microspheres of corn protein, zein, for an ivermectin drug delivery system. , 2005, Biomaterials.

[16]  David L. Kaplan,et al.  Role of pH and charge on silk protein assembly in insects and spiders , 2006 .

[17]  Ann-Christine Albertsson,et al.  Degradable polymer microspheres for controlled drug delivery , 2002 .

[18]  David L. Kaplan,et al.  Mechanism of silk processing in insects and spiders , 2003, Nature.

[19]  David L Kaplan,et al.  In vitro degradation of silk fibroin. , 2005, Biomaterials.

[20]  Robert A Newman,et al.  Silk-fibroin-coated liposomes for long-term and targeted drug delivery , 2006, International journal of nanomedicine.

[21]  P. M. Vogt,et al.  Spider silk fibres in artificial nerve constructs promote peripheral nerve regeneration , 2008, Cell proliferation.

[22]  G. Winter,et al.  Processing conditions for the formation of spider silk microspheres. , 2008, ChemSusChem.

[23]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[24]  L. Zhuge,et al.  Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization , 2007 .

[25]  G. P. Martin,et al.  Preparation of hydrophobic and hydrophilic albumin microspheres and determination of surface carboxylic acid and amino residues , 1997 .

[26]  R. Gurny,et al.  Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size , 1992 .

[27]  Thomas Scheibel,et al.  A conserved spider silk domain acts as a molecular switch that controls fibre assembly , 2010, Nature.

[28]  Helmuth Möhwald,et al.  Novel Hollow Polymer Shells by Colloid-Templated Assembly of Polyelectrolytes. , 1998, Angewandte Chemie.

[29]  Fuhua Huang,et al.  In vitro and in vivo characterization of a silk fibroin-coated polyester vascular prosthesis. , 2008, Artificial organs.

[30]  V. Shah,et al.  Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. , 1994, Journal of pharmaceutical sciences.

[31]  R. Arshady,et al.  Microspheres and microcapsules, a survey of manufacturing techniques: Part III: Solvent evaporation , 1990 .

[32]  I. Chin,et al.  pH-Triggered transition of silk fibroin from spherical micelles to nanofibrils in water , 2008 .

[33]  Daniel S Kohane,et al.  Microparticles and nanoparticles for drug delivery. , 2007, Biotechnology and bioengineering.

[34]  A. Terry,et al.  pH induced changes in the rheology of silk fibroin solution from the middle division of Bombyx mori silkworm. , 2004, Biomacromolecules.

[35]  K. Mita,et al.  Highly repetitive structure and its organization of the silk fibroin gene , 1994, Journal of Molecular Evolution.

[36]  M B McCarthy,et al.  Functionalized silk-based biomaterials for bone formation. , 2001, Journal of biomedical materials research.

[37]  F. Vollrath,et al.  Local tolerance to spider silks and protein polymers in vivo. , 2002, In vivo.

[38]  A. Bausch,et al.  Engineered Microcapsules Fabricated from Reconstituted Spider Silk , 2007 .

[39]  Thomas Scheibel,et al.  Formulation of poorly water-soluble substances using self-assembling spider silk protein , 2008 .

[40]  Young-Wook Won,et al.  Recombinant human gelatin nanoparticles as a protein drug carrier. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[41]  K Tanaka,et al.  Determination of the site of disulfide linkage between heavy and light chains of silk fibroin produced by Bombyx mori. , 1999, Biochimica et biophysica acta.

[42]  David L Kaplan,et al.  Mapping domain structures in silks from insects and spiders related to protein assembly. , 2004, Journal of molecular biology.

[43]  F. Grosse,et al.  Conserved C-termini of Spidroins are secreted by the major ampullate glands and retained in the silk thread. , 2004, Biomacromolecules.

[44]  J. Rieger,et al.  Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. , 2001, Angewandte Chemie.

[45]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[46]  V. Shah,et al.  Cross‐Linking of Gelatin Capsules and Its Relevance to Their in vitro‐ in vivo Performance , 1995 .

[47]  G. Vunjak‐Novakovic,et al.  Silk fibroin as an organic polymer for controlled drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[48]  A. Jayakrishnan,et al.  Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration , 1995 .

[49]  H. Palmer,et al.  Formation of Colloidal Dispersions of Organic Materials in Aqueous Media by Solvent Shifting , 2003 .

[50]  S. Rammensee,et al.  Assembly mechanism of recombinant spider silk proteins , 2008, Proceedings of the National Academy of Sciences.

[51]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[52]  David L Kaplan,et al.  Silk-based biomaterials. , 2003, Biomaterials.

[53]  Jinrong Yao,et al.  The preparation of regenerated silk fibroin microspheres. , 2007, Soft matter.

[54]  David L Kaplan,et al.  Sonication-induced gelation of silk fibroin for cell encapsulation. , 2008, Biomaterials.

[55]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[56]  T. Scheibel,et al.  Characterization of recombinantly produced spider flagelliform silk domains. , 2010, Journal of structural biology.

[57]  K. Langer,et al.  Desolvation process and surface characterisation of protein nanoparticles. , 2000, International journal of pharmaceutics.

[58]  R. Arletti,et al.  Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. , 2001, International journal of pharmaceutics.

[59]  J. Hardy,et al.  The role of salt and shear on the storage and assembly of spider silk proteins. , 2010, Journal of structural biology.

[60]  R. Arshady,et al.  Microspheres and microcapsules, a survey of manufacturing techniques Part II: Coacervation , 1990 .